Can I Take Vitamin B12 with Crestor (Rosuvastatin)?

Is There a Direct Interaction Between Vitamin B12 and Rosuvastatin?

No direct interaction exists. Rosuvastatin is a hydrophilic statin that undergoes minimal cytochrome P450 metabolism, with roughly 10% of its clearance handled by CYP2C9 [1]. Vitamin B12 does not inhibit, induce, or compete for any CYP isoenzyme. The two compounds occupy entirely separate metabolic pathways.

Why Rosuvastatin Has Fewer Supplement Conflicts

Unlike lipophilic statins such as atorvastatin or simvastatin (which rely heavily on CYP3A4), rosuvastatin is primarily eliminated through hepatic uptake via the OATP1B1 transporter and biliary excretion [1]. This pharmacokinetic profile means rosuvastatin has a shorter list of clinically meaningful drug and supplement interactions. B12, whether as cyanocobalamin, methylcobalamin, or hydroxocobalamin, does not interact with OATP transporters.

What the FDA Label Says

The Crestor prescribing information lists cyclosporine, gemfibrozil, lopinavir/ritonavir, and certain antacids as drugs requiring dose adjustment or separation [1]. Vitamin B12 appears nowhere in the label's drug interaction section. The Natural Medicines Comprehensive Database similarly rates this combination as having no known interaction.

Why the B12 Question Comes Up So Often

The concern is real, but it is indirect. Most patients searching for "Crestor and vitamin B12" are taking metformin alongside their statin for type 2 diabetes or insulin resistance. This combination of rosuvastatin plus metformin is extremely common: roughly 37% of U.S. Adults with type 2 diabetes are prescribed both a statin and metformin simultaneously [2].

Metformin Is the Actual B12 Depleter

Metformin reduces vitamin B12 absorption by interfering with the calcium-dependent binding of the intrinsic factor-B12 complex to ileal receptors [3]. A landmark randomized trial (the HOME study, N=390) found that metformin use for 4.3 years lowered serum B12 by 19% compared with placebo and increased homocysteine by 5% [3]. The American Diabetes Association (ADA) 2024 Standards of Care now recommend periodic B12 monitoring in all patients on long-term metformin, especially those with anemia or peripheral neuropathy [4].

The Symptom Overlap Problem

B12 deficiency causes a distal, symmetric polyneuropathy: numbness, tingling, and burning in the hands and feet [5]. Statin-associated muscle symptoms (SAMS) can present with similar sensory complaints. When a patient on both metformin and rosuvastatin develops tingling in the extremities, clinicians may reflexively blame the statin, leading to unnecessary discontinuation of a proven cardiovascular drug. Checking B12 (and methylmalonic acid) before stopping the statin could prevent that error.

B12 Deficiency: Who Is Actually at Risk?

Not every Crestor patient needs B12 supplementation. The risk concentrates in specific populations.

Metformin Users

The prevalence of biochemical B12 deficiency among metformin users ranges from 5.8% to 33%, depending on the threshold used and the study population [4]. Duration matters: risk increases substantially after 3 or more years of continuous metformin therapy. The HOME trial showed that each additional year of metformin added roughly 0.08 nmol/L to the deficit [3].

Older Adults

Adults over age 65 produce less intrinsic factor and gastric acid, both required for B12 liberation from food protein [5]. The Framingham Offspring Study found that 12% of adults aged 67 to 96 had serum B12 below 258 pmol/L, a threshold associated with neurological risk [6].

Patients on Proton Pump Inhibitors

Long-term PPI use (over 2 years) is associated with a 65% increased risk of B12 deficiency, per a Kaiser Permanente cohort study (N=25,956) [7]. Many statin patients are also prescribed PPIs for GERD, stacking the depletion risk.

Vegetarians and Vegans

Plant-based diets provide negligible B12 unless fortified. A patient who is vegan, on metformin, and on a PPI faces triple-layer depletion risk that no statin interaction would explain.

How to Monitor B12 Levels Correctly

A single serum B12 level can miss functional deficiency. The test has a sensitivity of only about 50% at the commonly used cutoff of 200 pg/mL [5].

The Two-Test Approach

The Endocrine Society and ADA recommend pairing serum B12 with methylmalonic acid (MMA). MMA rises when intracellular B12 is insufficient for the methylmalonyl-CoA mutase reaction, even if serum B12 looks borderline normal [5]. An MMA level above 0.4 micromol/L in a patient with a serum B12 between 200 and 400 pg/mL confirms functional deficiency.

When to Check

For patients on metformin plus a statin, check B12 and MMA at baseline, then annually [4]. If the patient develops new-onset neuropathy, paresthesias, or unexplained macrocytic anemia, test immediately rather than waiting for the annual screen. Dr. Irl Hirsch, Professor of Medicine at the University of Washington, has stated: "Every patient on metformin for more than two years deserves a B12 level. The test costs less than the workup for statin intolerance."

Dosing and Timing: How to Take Both

Because there is no interaction, you do not need to separate rosuvastatin and B12 by any specific time window. Take each at whatever time fits your routine.

Rosuvastatin Timing

Rosuvastatin can be taken at any time of day with or without food [1]. Unlike short-acting statins (fluvastatin IR, lovastatin), rosuvastatin has a 19-hour half-life, so morning or evening dosing produces equivalent LDL reduction.

B12 Dosing for Repletion vs. Maintenance

For documented deficiency (serum B12 <200 pg/mL or elevated MMA), the standard oral repletion dose is 1,000 mcg daily for 8 to 12 weeks, followed by a maintenance dose of 500 to 1,000 mcg daily [5]. Intramuscular injection (1,000 mcg monthly) is reserved for patients with pernicious anemia or malabsorption syndromes where oral absorption is unreliable.

Form of B12

Cyanocobalamin is the most studied and most affordable form. Methylcobalamin is the active coenzyme form and bypasses one metabolic conversion step, but head-to-head trials showing clinical superiority are lacking. Either form is acceptable for repletion.

What About Other Statins and B12?

The absence of interaction applies across the statin class. No statin (atorvastatin, simvastatin, pravastatin, pitavastatin, fluvastatin) has a documented pharmacokinetic or pharmacodynamic interaction with vitamin B12 [1].

A Statin-Specific Nuance Worth Knowing

Some early observational data suggested that statins might lower B12 or folate levels independently. A 2015 cross-sectional study (N=6,332) in the Journal of Clinical Lipidology reported a modest inverse association between statin use and serum B12 in older adults [8]. The effect size was small (roughly 10 pg/mL lower B12 in statin users vs. Non-users), was not adjusted for metformin use, and has not been replicated in randomized data. The ADA, ACC, and AHA do not recommend B12 monitoring based solely on statin use.

When to Talk to Your Doctor

Most patients can add over-the-counter B12 to their rosuvastatin regimen without a prescriber visit. Specific situations warrant a conversation.

Red Flags That Need Clinical Attention

Contact your prescriber if you experience new numbness or tingling in the feet or hands after starting (or being on) metformin plus a statin. Report any symptoms of macrocytic anemia: unusual fatigue, pallor, shortness of breath on exertion, or a swollen, glossy tongue. These may reflect B12 deficiency rather than a statin side effect, and the treatment is repletion, not statin discontinuation.

If You Are Considering High-Dose B12

Doses above 2,000 mcg daily are occasionally promoted for energy or neurological support. While B12 has no established upper tolerable intake level (the Institute of Medicine did not set one because toxicity data are insufficient), megadosing without confirmed deficiency offers no proven benefit [5]. Spending money on 5,000 mcg sublingual B12 "for energy" while already B12-replete is unlikely to change your LDL, your neuropathy risk, or your statin tolerability.

The Metformin-Statin-B12 Decision Framework

For the large population taking both metformin and a statin, a simple algorithm guides B12 management.

Step 1: Establish Baseline B12

At the time metformin is started (or at first opportunity if already on it), draw serum B12 and MMA.

Step 2: Risk-Stratify

Patients with two or more risk factors (metformin duration over 3 years, age over 65, PPI use, plant-based diet, prior gastric surgery) should receive empiric B12 supplementation at 1,000 mcg daily even before lab results return.

Step 3: Annual Recheck

Monitor serum B12 annually. If B12 falls below 300 pg/mL or MMA rises above 0.4 micromol/L, initiate or increase supplementation.

Step 4: Symptom-Triggered Reassessment

Any new neuropathy symptom on a statin should trigger B12/MMA testing before the statin is discontinued. The 2023 European Atherosclerosis Society (EAS) consensus statement on statin-associated muscle symptoms recommends excluding B12 deficiency, hypothyroidism, and vitamin D deficiency as contributors before attributing symptoms to the statin itself [9].

According to the EAS panel: "Clinicians should systematically evaluate common mimics of statin myopathy, including vitamin B12 deficiency, before classifying a patient as statin-intolerant" [9].

Supplements That Do Interact with Rosuvastatin

While B12 is safe, a few supplements require caution.

Red Yeast Rice

Red yeast rice contains monacolin K, which is chemically identical to lovastatin. Combining it with rosuvastatin doubles statin exposure and raises rhabdomyolysis risk [10].

Niacin (Vitamin B3) at Pharmacologic Doses

Niacin above 1,000 mg daily adds to statin-related myopathy and hepatotoxicity risk. The AIM-HIGH trial (N=3,414) showed no cardiovascular benefit from adding extended-release niacin to simvastatin and documented increased adverse events [11].

Grapefruit Juice

Grapefruit inhibits intestinal CYP3A4. This matters for atorvastatin and simvastatin but has minimal clinical effect on rosuvastatin, given its low CYP3A4 dependence [1]. The FDA label for Crestor does not include a grapefruit warning.

Coenzyme Q10

CoQ10 is frequently co-prescribed with statins for muscle symptoms. No pharmacokinetic interaction exists with rosuvastatin, and a 2018 Cochrane review found insufficient evidence that CoQ10 reduces statin myopathy [12].